MTHFR gene polymorphism as a risk factor for silent brain infarcts and white matter lesions in the Japanese general population: The NILS-LSA study

Stroke

Volumn 34, Issue 5, 2003, Pages 1130-1135

  Kohara, Katsuhiko ^a   Fujisawa, Michiko ^b   Ando, Fujiko ^b   Tabara, Yasuharu ^a   Niino, Naoakira ^b   Miki, Tetsuro ^a   Shimokata, Hiroshi ^b  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

Author keywords

Amine oxidoreductases; Brain infarction; Elderly; Polymorphism; White matter

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); OXIDOREDUCTASE;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; BRAIN INJURY; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE; GENE MUTATION; GENOTYPE; HUMAN; JAPAN; MALE; NORMAL HUMAN; POPULATION; PREVALENCE; PRIORITY JOURNAL; RISK; RISK FACTOR; WHITE MATTER;

ADULT; AGE OF ONSET; AGED; AMINO ACID SUBSTITUTION; BRAIN; CEREBRAL INFARCTION; CODON; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCOSE INTOLERANCE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERLIPIDEMIAS; HYPERTENSION; JAPAN; LIFE STYLE; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION, MISSENSE; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; SMOKING;

EID: 0037967343     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000069163.02611.B0     Document Type: Article

References (33)

1. Shinkawa A, Ueda K, Kiyohara Y, Kato I, Sueishi K, Tsuneyoshi M, Fujishima M. Silent cerebral infarction in a community-based autopsy series in Japan: the Hisayama Study. Stroke. 1995;26:380-385.
2. Longstreth WT Jr, Bernick C, Manolio TA, Bryan N, Jungreis CA, Price TR. Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol. 1998;55: 1217-1225.
3. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study. Stroke. 2002;33:21-25.
4. Kobayashi S, Okada K, Koide H, et al. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke. 1997;28:1932-1939.
5. Bernick C, Kuller L, Dulberg C, Longstreth WT Jr, Manolio T, Beauchamp N, Price T, for the Cardiovascular Health Study Collaborative Research Group. Silent MRI infarcts and the risk of future stroke: the Cardiovascular Health Study. Neurology. 2001;57:1222-1229.
6. Kuller LH, Shemanski L, Manolio T, et al. Relationship between ApoE, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke. 1998;29:388-398.
7. Howard G, Wagenknecht LE, Cai J, Cooper L, Kraut MA, Toole JF. Cigarette smoking and other risk factors for silent cerebral infarction in the general population. Stroke. 1998;29:913-917.
8. Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, Breteler MM. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol. 2002;51:285-289.
9. Notsu Y, Nabika T, Park H-Y, Masuda J, Kobayashi S. Evaluation of genetic risk factors for silent brain infarction. Stroke. 1999;30: 1881-1886.
10. Matsui T, Arai H, Yuzuriha T, Yao H, Miura M, Hashimoto S, Higuchi S, Matsushita S, Morikawa M, Kato A, Sasaki H. Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people. Stroke. 2001;32:1116-1119.
11. Ueland M, Refsum H, Beresford SAA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr. 2000;72:324-332.
12. Ueland PM, Hustad S, Schneede J, Refsum H, Vollset SE. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci. 2001;22:195-201.
13. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274: 1049-1057.
14. Brattstrom L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 1998;98:2520-2526.
15. Shimokata H, Ando F, Niino N. A new comprehensive study on aging: the National Institute for Longevity Sciences, Longitudinal Study of Aging (NILS-LSA). J Epidemiol. 2000;10(suppl):S1-S9.
16. Matsubayashi K, Okumiya K, Wada T, Osaki Y, Fujisawa M, Doi Y, Ozawa T. Postural dysregulation in systolic blood pressure is associated with worsened scoring on neurobehavioral function tests and leukoariosis in the older elderly living in a community. Stroke. 1997;28:2169-2173.
17. Kohara K, Jiang YN, Igase M, Takata Y, Fukuoka T, Okura T, Kitami Y, Hiwada K. Postprandial hypotension is associated with asymptomatic cerebrovascular damage in essential hypertensive patients. Hypertension. 1999;33:565-568.
18. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Hauvel LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
19. Takagi M, Nishioka M, Kakihara H, Kitabayashi M, Inoue H, Kawakami B, Oka M, Imanaka T. Characterization of DNA polymerase from Pyrococcus sp. strain KOD1 and its application to PCR. Appl Environ Microbiol. 1997;63:4504-4510.
20. Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, Breteler MM. Homocysteine, silent brain infarcts, and white matter lesions: the Rotterdam Scan Study. Ann Neurol. 2002;51:285-289.
21. Dekou V, Whincup P, Papacosta O, Ebrahim S, Lennon L, Ueland PM, Refsum H, Humphries SE, Gudnason V. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British Regional Heart Study. Atherosclerosis. 2001;154:659-666.
22. Price TR, Manolio TA, Kronmal RA, Kittner SJ, Yue NC, Robbins J, Anton-Culver H, O'Leary DH. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults: the Cardiovascular Health Study (CHS) Collaborative Research Group. Stroke. 1997;28:1158-1164.
23. Sato R, Bryan RN, Fried LP. Neuroanatomic and functional correlates of depressed mood: the Cardiovascular Health Study. Am J Epidemiol. 1999;150:919-929.
24. Kohara K, Zhao B, Jiang YN, Takata Y, Fukuoka T, Igase M, Miki T, Hiwada K. Relation of left ventricular hypertrophy and geometry to asymptomatic cerebrovascular damage in essential hypertension. Am J Cardiol. 1999;83:367-370.
25. Kohara K, Igase M, Jiang YN, Fukuoka T, Maguchi M, Okura T, Kitami Y, Hiwada K. Asymptomatic cerebrovascular damages in essential hypertension in the elderly. Am J Hypertens. 1997;10:829-835.
26. Yoo J-H, Choi G-D, Kang S-S. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Arterioscler Thromb Vasc Biol. 2000;20:1921-1925.
27. Nishiyama M, Kato Y, Hashimoto M, Yukawa S, Omori K. Apolipoprotein E, methylenetetrahydrofolate reductase (MTHFR) mutation and the risk of senile dementia: an epidemiological study using the polymerase chain reaction (PCR) method. J Epidemiol. 2000;10: 163-172.
28. Gusseklooa J, Heijmansb BT, Slagboomb PE, Lagaaya AM, D L Knooka DL, Westendorp RGJ. Thermolabile methylene tetrahydrofolate reductase gene and the risk of cognitive impairment in those over 85. J Neurol Neurosurg Psychiatry. 1999;67:535-538.
29. Pollak RD, Pollak A, Idelson M, Bejarano-Achache I, Doron D, Blumenfeld A. The C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene and vascular dementia. J Am Geriatr Soc. 2000;48:664-668.
30. El Kossi MM, Zakhary MM. Oxidative stress in the context of acute cerebrovascular stroke. Stroke. 2000;31:1889-1892.
31. Mayer O Jr, Äimon J, Rosolová H, Hromádka M, Äubrt I, Vobrubová I. The effects of folate supplementation on some coagulation parameters and oxidative status surrogates. Eur J Clin Pharmacol. 2002;58:1-5.
32. Liu PK, Hsu CY, Dizdaroglu M, Floyd RA, Kow YW, Karakaya A, Rabow LE, Cui JK. Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion. J Neurosci. 1996;16: 6795-6806.
33. Liu PK, Grossman RG, Hsu CY, Robertson CS. Ischemic injury and faulty gene transcripts in the brain. Trends Neurosci. 2001;24:581-588.